Witczak Bartlomiej J, Jenssen Trond, Endresen Knut, Røislien Jo, Hartmann Anders
Department of Medicine, Section of Nephrology, Rikshospitalet, University of Oslo, Oslo, Norway.
Transplantation. 2007 Aug 15;84(3):356-61. doi: 10.1097/01.tp.0000276935.31584.4c.
There is a high incidence of silent coronary artery disease (CAD) in patients with diabetes. We wanted to investigate risk factors for mortality, and especially CAD, in a well-defined cohort of diabetic nephropathy transplant candidates accepted for transplantation.
From 1999 through 2004, 155 patients underwent work up for living or deceased kidney (KA) or simultaneous pancreas-kidney (SPK) transplantation. The work up included coronary angiography for all patients and 136 were accepted. Mean (SD) age was 50 (12) years, 62% had type 1 diabetes, 73% were males, and 34% were on dialysis. Mean follow-up from time of acceptance for transplantation was 3.6 (1.9) years.
Survival of KA transplanted patients was 97% at 1 year, 89% at 3 years, and 76% at 5 years, whereas in SPK patients 100%, 94%, and 90%, respectively (P=0.065). One- and 3- year survival was only 57% and 20% in those remaining wait-listed (P<0.001). In univariate analysis mortality was associated with KA transplantation (hazard ratio [HR]=0.30, P=0.011) and SPK transplantation (HR=0.10, P=0.001), and age (HR=1.04, P=0.014). In multivariable analysis, KA transplantation (HR=0.28, P=0.006), SPK transplantation (HR=0.09, P=0.001), age (HR=1.06, P=0.002), type 2 diabetes (HR=0.14, P=0.003), and duration of diabetes (HR=0.94, P=0.019) were parameters associated with mortality.
The only modifiable risk factor was transplantation with risk reduction up to 90%. CAD was not a risk factor for mortality when medically treated and revascularized according to standard guidelines.
糖尿病患者中无症状冠状动脉疾病(CAD)的发病率很高。我们想在一组明确的等待移植的糖尿病肾病患者队列中,研究死亡率的危险因素,尤其是CAD的危险因素。
1999年至2004年,155例患者接受了活体或尸体肾(KA)移植或胰肾联合移植(SPK)的术前检查。检查包括对所有患者进行冠状动脉造影,其中136例被接受移植。平均(标准差)年龄为50(12)岁,62%为1型糖尿病患者,73%为男性,34%正在接受透析。从接受移植时起的平均随访时间为3.6(1.9)年。
KA移植患者1年生存率为97%,3年生存率为89%,5年生存率为76%;而SPK移植患者的生存率分别为100%、94%和90%(P = 0.065)。仍在等待名单上的患者1年和3年生存率仅为57%和20%(P < 0.001)。单因素分析显示,死亡率与KA移植(风险比[HR]=0.30,P = 0.011)、SPK移植(HR = 0.10,P = 0.001)以及年龄(HR = 1.04,P = 0.014)相关。多变量分析显示,KA移植(HR = 0.28,P = 0.006)、SPK移植(HR = 0.09,P = 0.001)、年龄(HR = 1.06,P = 0.002)、2型糖尿病(HR = 0.14,P = 0.003)以及糖尿病病程(HR = 0.94,P = 0.019)是与死亡率相关的参数。
唯一可改变的危险因素是移植,风险降低可达90%。按照标准指南进行药物治疗和血运重建时,CAD不是死亡的危险因素。